Safety and efficacy of sorafenib therapy in patients with hepatocellular carcinoma: final outcome from the Chinese patient subset of the GIDEON study

We report data from the final analysis of the Chinese subset of the GIDEON (the Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) study, which evaluated the safety and efficacy of sorafenib in Child-Pugh A, B and C patients with unresectab...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Sheng-Long, Chen, Xiaoping, Yang, Jiamei, Bie, Ping, Zhang, Shuijun, Liu, Fengyong, Liu, Luming, Zhou, Jie, Dou, Kefeng, Hao, Chunyi, Shao, Guoliang, Xia, Qiang, Chen, Yajin, Yang, Jijin, Deng, Xiaxing, Liu, Yunpeng, Yuan, Yunfei, Fu, Zhiren, Nakajima, Keiko, Yip, Christina S.M., Lu, Zhengguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872739/
https://www.ncbi.nlm.nih.gov/pubmed/26735891
http://dx.doi.org/10.18632/oncotarget.6781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872739/
https://www.ncbi.nlm.nih.gov/pubmed/26735891
http://dx.doi.org/10.18632/oncotarget.6781

Ejemplares similares